Malaria is currently one of the most imperative parasitic diseases in developing countries. Artesunate has a short half-life, low aqueous solubility and resultant poor and erratic absorption upon oral administration, which translate to low bioavailability. Mefloquine is eliminated slowly with a terminal elimination half-life of approximately 20 days and has neuropsychiatric side effects. Novel drug delivery systems have been utilised to optimise chemotherapy with currently available antimalarial drugs. Pheroid™ technology is a patented drug delivery system which has the ability to capture, transport and deliver pharmaceutical compounds. Pheroid™ technology may play a key role in ensuring effective delivery and enhanced bioavailability of novel antimalarial drugs. The aim of this study was to evaluate the possible efficacy and bioavailability enhancement of the selected antimalarial drugs, artesunate and mefloquine, in combination with Pheroid™ vesicles. The in vitro efficacy of artesunate and mefloquine co-formulated in the oil phase of Pheroid™ vesicles and entrapped in Pheroid™ vesicles 24 hours after manufacturing were investigated against a 3D7 chloroquine-sensitive strain of Plasmodium falciparum. Parasitemia (%) was quantified with flow cytometry after incubation periods of 48 and 72 hours. Drug sensitivity was expressed as 50% inhibitory concentration (IC50) values. An in vivo bioavailability study with artesunate and mefloquine was also conducted in combination with Pheroid™ vesicles, using a mouse model. A sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to analyse the drug levels. C57 BL6 mice were used during this study. The selected antimalarial drugs were administered at a dose of 20 mg/kg with an oral gavage tube. Blood samples were collected by means of tail bleeding. The in vitro drug sensitivity assays revealed that artesunate, co-formulated in the oil phase of Pheroid™ vesicles and evaluated after a 48 hour incubation period, decreased the IC50 concentration significantly by 90%. Extending the incubation period to 72 hours decreased the IC50 concentration of artesunate, also co-formulated in the oil phase of Pheroid ™ vesicles significantly by 72%. No statistically significant differences between the reference and Pheroid™ vesicle groups were achieved when artesunate was entrapped 24 hours after manufacturing of Pheroid™ vesicles. Mefloquine co-formulated in the oil phase of Pheroid™ vesicles and evaluated after a 48 hour incubation period decreased the IC50 concentration by 36%. Extending the incubation period to 72 hours increased the efficacy of the Pheroid™ vesicles and the IC50 concentration was significantly decreased by 51%. In contrast with the results obtained with artesunate, entrapment of mefloquine in Pheroid™ vesicles 24 hours after manufacturing decreased the IC50 concentration significantly by 66%. The LC-MS/MS method was found to be sensitive, selective and accurate for the determination of artesunate and its active metabolite, dihydroartemisinin (DHA) in mouse plasma and mefloquine in mouse whole blood. Most of the artesunate plasma concentrations were below the limit of quantification in the reference group and relatively high outliers were observed in some of the samples. The mean artesunate levels of the Pheroid™ vesicle group were lower compared to the reference group, but the variation within the Pheroid™ vesicle group lessened significantly. The mean DHA concentrations of the Pheroid™ vesicle group were significantly higher. DHA obtained a higher peak plasma drug concentration with the Pheroid™ vesicle group (173.0 ng/ml) in relation to the reference group (105.0 ng/ml) and at a much faster time (10 minutes in Pheroid™ vesicles in contrast to 30 minutes of the reference group). Pharmacokinetic models could not be constructed due to blood sampling per animal limitation. The incorporation of mefloquine in Pheroid™ vesicles did not seem to have improved results in relation to the reference group. No statistical significant differences were observed in the pharmacokinetic parameters between the two groups. The relative bioavailability (%) of the Pheroid™ vesicle incorporated mefloquine was 7% less bioavailable than the reference group. / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2010.

Anatoxin-a (ANTX) is a neurotoxin produced by several freshwater cyanobacteria and has been implicated in the death of livestock and domestic animals from consumption of tainted surface waters. ANTX is unstable under normal conditions and is somewhat problematic to extract and study. Accelerated solvent extraction (ASE) combined with liquid chromatography-mass spectrometry (LC/MS) was used to develop an efficient extraction and analytical method for both ANTX and the more commonly encountered hepatotoxic microcystins produced by cyanobacteria. The effects of nitrogen supply on the cellular production and release of ANTX was investigated in Aphanizomenon issatschenkoi (Ussaczew) Proschkina-Lavrenko (Nostocales). In contrast to the predictions of the carbonnutrient balance hypothesis, the maximum production was observed under moderate N stress. In addition, steady state fugacity-based models were employed to investigate ANTX’s distribution and fate in freshwater ecosytems. ANTX was not found to be very persistent in aquatic ecosystems and did not appear to bioaccumulate in fish, at least not from the dissolved phase.

Malaria is currently one of the most imperative parasitic diseases in developing countries. Artesunate has a short half-life, low aqueous solubility and resultant poor and erratic absorption upon oral administration, which translate to low bioavailability. Mefloquine is eliminated slowly with a terminal elimination half-life of approximately 20 days and has neuropsychiatric side effects. Novel drug delivery systems have been utilised to optimise chemotherapy with currently available antimalarial drugs. Pheroid™ technology is a patented drug delivery system which has the ability to capture, transport and deliver pharmaceutical compounds. Pheroid™ technology may play a key role in ensuring effective delivery and enhanced bioavailability of novel antimalarial drugs. The aim of this study was to evaluate the possible efficacy and bioavailability enhancement of the selected antimalarial drugs, artesunate and mefloquine, in combination with Pheroid™ vesicles. The in vitro efficacy of artesunate and mefloquine co-formulated in the oil phase of Pheroid™ vesicles and entrapped in Pheroid™ vesicles 24 hours after manufacturing were investigated against a 3D7 chloroquine-sensitive strain of Plasmodium falciparum. Parasitemia (%) was quantified with flow cytometry after incubation periods of 48 and 72 hours. Drug sensitivity was expressed as 50% inhibitory concentration (IC50) values. An in vivo bioavailability study with artesunate and mefloquine was also conducted in combination with Pheroid™ vesicles, using a mouse model. A sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to analyse the drug levels. C57 BL6 mice were used during this study. The selected antimalarial drugs were administered at a dose of 20 mg/kg with an oral gavage tube. Blood samples were collected by means of tail bleeding. The in vitro drug sensitivity assays revealed that artesunate, co-formulated in the oil phase of Pheroid™ vesicles and evaluated after a 48 hour incubation period, decreased the IC50 concentration significantly by 90%. Extending the incubation period to 72 hours decreased the IC50 concentration of artesunate, also co-formulated in the oil phase of Pheroid ™ vesicles significantly by 72%. No statistically significant differences between the reference and Pheroid™ vesicle groups were achieved when artesunate was entrapped 24 hours after manufacturing of Pheroid™ vesicles. Mefloquine co-formulated in the oil phase of Pheroid™ vesicles and evaluated after a 48 hour incubation period decreased the IC50 concentration by 36%. Extending the incubation period to 72 hours increased the efficacy of the Pheroid™ vesicles and the IC50 concentration was significantly decreased by 51%. In contrast with the results obtained with artesunate, entrapment of mefloquine in Pheroid™ vesicles 24 hours after manufacturing decreased the IC50 concentration significantly by 66%. The LC-MS/MS method was found to be sensitive, selective and accurate for the determination of artesunate and its active metabolite, dihydroartemisinin (DHA) in mouse plasma and mefloquine in mouse whole blood. Most of the artesunate plasma concentrations were below the limit of quantification in the reference group and relatively high outliers were observed in some of the samples. The mean artesunate levels of the Pheroid™ vesicle group were lower compared to the reference group, but the variation within the Pheroid™ vesicle group lessened significantly. The mean DHA concentrations of the Pheroid™ vesicle group were significantly higher. DHA obtained a higher peak plasma drug concentration with the Pheroid™ vesicle group (173.0 ng/ml) in relation to the reference group (105.0 ng/ml) and at a much faster time (10 minutes in Pheroid™ vesicles in contrast to 30 minutes of the reference group). Pharmacokinetic models could not be constructed due to blood sampling per animal limitation. The incorporation of mefloquine in Pheroid™ vesicles did not seem to have improved results in relation to the reference group. No statistical significant differences were observed in the pharmacokinetic parameters between the two groups. The relative bioavailability (%) of the Pheroid™ vesicle incorporated mefloquine was 7% less bioavailable than the reference group. / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2010.

The new field of ‘omics’ has spawned the development of metaproteomics, an approach that has the ability to identify and decipher the metabolic functions of a proteome derived from a microbial community that is largely uncultivable. With the development and availabilities of high throughput proteomics, high performance liquid chromatography coupled to mass spectrometry (MS) has been leading the field for metaproteomics. MS-based metaproteomics has been successful in its’ investigations of complex microbial communities from soils to the human body. Like the environment, the human body is host to a multitude of microorganisms that reside within the skin, oral cavity, vagina, and gastrointestinal tract, referred to as the human microbiome. The human microbiome is made up of trillions of bacteria that outnumber human genes by several orders of magnitude. These microbes are essential for human survival with a significant dependence on the microbes to encode and carryout metabolic functions that humans have not evolved on their own. Recently, metaproteomics has emerged as the primary technology to understand the metabolic functional signature of the human microbiome. Using a newly developed integrated approach that combines metagenomics and metaproteomics, we attempted to address the following questions: i) do humans share a core functional microbiome and ii) how do microbial communities change in response to disease. This resulted in a comprehensive identification and characterization of the metaproteome from two healthy human gut microbiomes. These analyses have resulted in an extended application to characterize how Crohn’s disease affects the functional signature of the microbiota. Contrary to measuring highly complex and representative gut metaproteomes is a less complex, controlled human-derived microbial community present in the gut of gnotobiotic mice. This human gut model system enhanced the capability to directly monitor fundamental interactions between two dominant phyla, Bacteroides and Firmicutes, in gut microbiomes colonized with two or more phylotypes. These analyses revealed membership abundance and functional differences between phylotypes when present in either a binary or 12-member consortia. This dissertation aims to characterize host microbial interactions and develop MS-based methods that can provide a better understanding of the human gut microbiota composition and function using both approaches.

Ziel der vorliegenden Promotionsarbeit war die Untersuchung von Sepsis-assoziierten Veränderungen des Arachidonsäure (AA)-Metabolismus und die Identifikation differentiell regulierter AA-Metabolite mit Prüfung ihres diagnostischen Potentials bei Patienten mit Sepsis unter Anwendung eines in-vitro Lipopolysaccharid (LPS) Vollblutaktivierungs-Modells. In Zellüberständen von nicht-aktiviertem und LPS-aktiviertem Heparinblut (25 Sepsis- Patienten, 15 Gesunde) wurden AA-Metabolite mittels Flüssigkeitschromatographie-Tandem- Massenspektrometrie analysiert. In einer unabhängigen Kohorte (10 Sepsis-Patienten, 3 Gesunde) wurden nach RNA-Isolation aus Zellmaterial zusätzlich Target-Gene des AAMetabolismus (Cyclooxygenase (COX)-2 und mikrosomale Prostaglandin-E-Synthase (mPGES)-1 mittels quantitativer Reverse Transkriptase-Polymerase Kettenreaktion (RT-PCR) untersucht. Es konnte eine differentielle Freisetzung von AA, AA-Analoga und der COX-assoziierten Metabolite Prostaglandin (PG) E2, 11-Hydroxyeicosatetraensäure (HETE) und Thromboxan (TX) B2 zwischen Patienten und gesunden Kontrollpersonen gezeigt werden. Sepsis-Patienten wiesen dabei gegenüber Gesunden eine deutlich reduzierte Freisetzung von AA und den COXassoziierten Metaboliten 11-HETE und PGE2 auf. Das Ausmaß der reduzierten Mediatorenfreisetzung bei Sepsis-Patienten war mit der Schwere der Erkrankungssymptomatik und dem klinischen Outcome assoziiert. Auf Genexpressionsebene zeigte sich eine reduzierte Induzierbarkeit der COX-2 mRNA-Expression bei Sepsis-Patienten gegenüber Gesunden, jedoch eine erhaltene Induzierbarkeit auf der Ebene der mPGES-1.

Orientador: Pedro de Magalhães Padilha / Resumo: O mercúrio é um metal tóxico, de distribuição ubíqua, com capacidade para bioacumulação e biomagnificação, que provoca alterações em biomoléculas importantes no metabolismo e contribui para o estabelecimento do estresse oxidativo em organismos aquáticos. Logo, o presente estudo teve por objetivo identificar e avaliar possíveis biomarcadores proteicos e/ou enzimáticos da toxicidade do mercúrio em peixes da região amazônica, por meio do estudo metaloproteômico e avaliação do estresse oxidativo. Foram utilizadas metodologias de fracionamento e identificação de proteínas por eletroforese bidimensional (2D PAGE) associada à espectrometria de massas (MS), mapeamento do mercúrio, em spots proteicos, por espectrometria de absorção atômica em forno de grafite (GFAAS) e avaliação de marcadores de estresse oxidativo. As espécies utilizadas foram o Plagioscion squamosissimus (corvina) e Colossoma macropomum (tambaqui), coletados na área da Usina Hidrelétrica de Jirau (rio Madeira-RO), que foram selecionadas em função da abundância populacional, interesse para a pesca e posição diferente na cadeia trófica (carnívoro e onívoro, respectivamente). Os tecidos amostrados foram o hepático, renal e muscular. Os resultados obtidos demonstraram maior concentração de mercúrio total no P. squamosissimus, espécie carnívora, e padrão de distribuição deste elemento igual para ambas as espécies (fígado>rim>músculo). Há tendência para maior atividade enzimática nos tecidos hepático e renal da espécie com... (Resumo completo, clicar acesso eletrônico abaixo) / Doutor

Os agrotóxicos, quando presentes na água, são definidos como micropoluentes: mesmo em baixas concentrações, conferem à água características de toxicidade. Aponta-se o RS como o quarto estado do Brasil com maior volume de vendas anuais de agrotóxicos, chegando a mais de 50 mil toneladas por ano. Desde 2014 está em vigência no território gaúcho uma portaria estadual que acrescenta a exigência de 46 parâmetros de agrotóxicos no padrão de potabilidade da água, além dos 27 já exigidos pela portaria nacional. Neste trabalho, 89 pesticidas foram avaliados conforme três métodos teóricos de predição de risco de contaminação em mananciais subterrâneos e superficiais: índice Ground Ubiquity Score (GUS), método Screening da USEPA e método de GOSS, baseados nas propriedades físico-químicas dos pesticidas. Nos anos de 2015 e 2016, foram realizadas 143 coletas de água para consumo humano em 45 municípios da bacia hidrográfica do Alto Jacuí (G-50), a que possui a maior taxa de aplicação de agrotóxicos do estado, para análises de vigilância através de laboratório contratado, envolvendo os 89 pesticidas presentes na portaria nacional e estadual. Em paralelo, 183 pesticidas presentes em uma solução-padrão foram empregados no desenvolvimento de um novo método de análise multiresíduos, com etapas de pré-tratamento por filtração seguidas por extração em fase sólida e LC-MS/MS, aplicada para os três maiores municípios da G-50 (Carazinho, Soledade e Cruz Alta) em amostras de água bruta e tratada, durante quatro períodos de aplicação de agrotóxicos dos principais cultivos agrícolas da região. Dos pesticidas mencionados nas portarias nacional e estadual, 12 foram classificados com o maior risco de contaminação tanto em água superficial e subterrânea de acordo com os três métodos teóricos empregadas. Nas análises de vigilância foi detectado permetrina em Carazinho e alaclor em Espumoso. No método desenvolvido, 75 pesticidas foram validados de acordo com os critérios propostos e atingiram limites de detecção (LD) e limites de quantificação (LQ) que variaram de 10 a 300 ng L-1. Na aplicação do método nas coletas dos três municípios da G-50 não houve detecção de nenhum pesticida. / Agrochemicals, when present in water, are defined as micropollutants, thus giving the water toxic characteristics, even at low concentrations. The Rio Grande do Sul state in Brazil was found to rank fourth in annual agrochemical sales in the country, surpassing 50 thousand tons per year. A state regulation in effect in the RS state since 2014 requires the inclusion of 46 new agrochemical parameters concerning the standards for potable drinking water, in addition to 27 existing parameters mandated by national ordinance. Seventy-five pesticides were evaluated based on three theoretical methodologies of contamination risk prediction in underground and surface water sources, by measuring the physicochemical properties of pesticides: GUS index, USEPA screening method and Goss method. In 2015 and 2016, 143 water samples were collected from sources of potable water in 45 municipalities located in the Alto Jacuí river basin, a region which has the highest pesticide application rate in the RS state. A private laboratory analyzed samples from 89 pesticides present in the national and state regulation. Paralely, 183 pesticides were evaluated by a new multi-residue analysis method. Filtration was conducted in the pre-treatment steps, followed by a solid phase extraction liquid chromatography coupled with mass spectrometry analysis (SPE-LC-MS/MS) of raw and treated water samples from the three largest G-50 municipalities (Carazinho, Soledade and Cruz Alta), during the four pesticide application periods of the main crops cultivated in the region. Twelve pesticides were classified as of high risk in terms of contamination for both surface and groundwater, in accordance with the three theoretical methodologies implemented. During analysis of the surveillance data collected, the pesticides permethrin and alachlor were found in Carazinho and Espumoso, respectively. Through the methodology developed, 75 pesticides were evaluated according to the criteria proposed, reaching lower detection limit (LD) and quantification limit (LQ) ranging from 10 to 300 ng L-1, respectively. During the implementation of the methodology for sample collections in the three G-50 municipalities, no pesticides were detected.

A presença de resíduos de medicamentos antibacterianos em alimentos é um importante problema de saúde pública. Estas substâncias podem estar presentes nos alimentos em níveis inaceitáveis como resultados de práticas produtivas inadequadas. Devido a estas preocupações, são estabelecidos limites máximos de resíduos para estas substâncias (LMRs). No caso das sulfonamidas, este valor de LMR refere-se à soma do princípio ativo e de todos seus metabólitos. Neste trabalho, identificam-se e caracterizam-se metabólitos de sulfaquinoxalina (SQX) em diversas espécies animais. Dentro do processo investigativo, foram realizados estudos comparativos de métodos de extração, processos de validação e determinação de efeito de matriz. Foi elaborado e proposto um modelo para a priorização de fármacos baseado em análise de risco e discutiu-se o panorama atual da presença de resíduos de sulfonamidas em amostras ambientais. A investigação da formação de metabólitos de SQX in vitro e in vivo levaram à identificação de três compostos, dois deles ainda não descritos na literatura: N4-acetil-SQX, SQX-OH e N4-acetil-SQX-OH. O perfil de formação destes compostos em diversas espécies animais foi analisado e discutido. / The presence of antibacterial drugs residues in food is an important public health issue. These substances can be present in food at unacceptable levels due to inappropriate veterinary practices. Because of that, maximum residue levels (MRL) are established for these compounds. In the sulfonamide drugs case, this value corresponds to the sum of parent drug and their metabolites. In the present work, sulfaquinoxaline (SQX) metabolites were identified and characterized in several animal species. Inside that investigation process, several studies were developed about extraction methods, validation processes and matrix effects determination. A model for drugs residues prioritization based on risk analysis was proposed. Also, the state-of-art of sulfonamides residues analysis in environmental samples was discussed. The in vivo and in vitro investigation of SQX metabolites formation lead us to the identification of 3 compounds, 2 of them previously unreported: N4-acetyl-SQX, SQX-OH and N4-acetyl-SQX-OH. The formation profile of these compounds in several animal species was analyzed and discussed.

Submitted by FERNANDA TANAMATI null (fertanamati@gmail.com) on 2018-03-22T00:14:15Z No. of bitstreams: 1 Tese_Tanamati_versão final.pdf: 1118298 bytes, checksum: ad444e697e657dd704d25b099b8eeede (MD5) / Approved for entry into archive by Alexandra Maria Donadon Lusser Segali null (alexmar@fcav.unesp.br) on 2018-03-22T10:54:04Z (GMT) No. of bitstreams: 1 tanamati_f_dr_jabo.pdf: 1118298 bytes, checksum: ad444e697e657dd704d25b099b8eeede (MD5) / Made available in DSpace on 2018-03-22T10:54:04Z (GMT). No. of bitstreams: 1 tanamati_f_dr_jabo.pdf: 1118298 bytes, checksum: ad444e697e657dd704d25b099b8eeede (MD5) Previous issue date: 2018-02-27 / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / A mastite em búfalas leiteiras causa perdas econômicas devido à diminuição da produção de leite, além de ter um efeito negativo no bem-estar dos animais. Deste modo, foram realizados dois estudos: o objetivo do estudo I foi avaliar o nível de expressão dos genes da lactoferrina (LTF), fator de necrose tumoral alfa (TNF-α), interleucina-1 beta (IL-1β), interleucina-8 (IL-8), e toll-like receptors 2 (TLR-2) e 4 (TLR-4) em búfalas Murrah com e sem mastite subclínica. Amostras de leite de 12 búfalas com mastite e 12 de búfalas sem mastite foram coletadas, para a extração de RNA, síntese de cDNA e validação dos perfis de expressão por qRT-PCR. O ΔΔCt foi estimado utilizando contrastes ortogonais da expressão dos genes alvo corrigidos para a expressão dos genes housekeeping entre os tratamentos. A expressão dos genes TLR-2, TLR-4, TNF-α, IL-1β e IL-8 foi regulada positivamente em búfalos com mastite, enquanto que o gene LTF não apresentou expressão diferencial. O estudo desses genes da função imune que são ativos na glândula mamária é importante para o desenvolvimento de estratégias destinadas a preservar a saúde do úbere. O objetivo do estudo II foi avaliar as proteínas presentes no soro do leite de búfalas com e sem mastite subclínica, utilizando uma abordagem proteômica para identificar proteínas diferencialmente expressas e potencial biomarcador para a doença. Para isso, 16 amostras de leite de búfalas Murrah foram coletadas, sendo oito animais com e oito animais sem mastite subclínica. O método contagem espectral foi utilizado para quantificar a abundância relativa das proteínas individuais e os bancos de dados de proteínas anotadas para Bubalus bubalis e para Bos taurus foram utilizados na análise. Após integração das anotações genéticas das referências de búfalos e bovinos, foram identificadas 1.033 proteínas, das quais 156 proteínas foram diferencialmente reguladas entre animais sadios e infectados. Foram identificados 18 processos biológicos nos quais essas proteínas participam e a catelicidina-3 foi identificada como um potencial biomarcador da mastite subclínica. Os resultados são importantes para compreender melhor o comportamento da mastite na glândula mamária das búfalas e, portanto, podem auxiliar no diagnóstico precoce da doença. / Mastitis in dairy buffalo causes economic losses due to decreased milk production, along with having a negative effect on the animals’ welfare. Thus, two studies were performed: the objective of study I was to evaluate the expression levels of lactoferrin (LTF), tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin- 8 (IL-8) and toll-like receptors 2 (TLR-2) and 4 (TLR-4) in Murrah buffaloes with and without subclinical mastitis. Milk samples were collected from 12 buffaloes with mastitis and 12 buffaloes without mastitis for RNA extraction, cDNA synthesis, and validation of expression profiles by qRT-PCR. The ΔΔCt was estimated using orthogonal contrasts of the target genes expression adjusted for the expression of the housekeeping genes between both treatments. The expression of the TLR-2, TLR-4, TNF-α, IL-1β and IL-8 genes were upregulated in buffaloes with mastitis, while the LTF gene showed no differential expression. The study of these immune function genes that are active in the mammary gland is important for the development of strategies aimed at preserving the health of the udder. The objective of study II was to evaluate the proteins present in the milk whey from buffaloes with and without subclinical mastitis, using a proteomic approach to identify differentially expressed proteins and potential biomarkers for the disease. For this, 16 samples of Murrah buffalo milk were collected, comprised of eight animals with and eight animals without subclinical mastitis. The spectral counting method was used to quantify the relative abundance of the individual proteins, and the databases of proteins annotated for Bubalus bubalis and for Bos taurus were used in the analysis. After integrating the gene annotations from the buffalo and bovine references, a total of 1,033 proteins were identified, of which 156 proteins were differentially regulated between healthy and affected animals. 18 biological processes in which these proteins participate were identified, and cathelicidin-3 was identified as a potential biomarker of subclinical mastitis. These results are important to better understand the behavior of mastitis in the buffalo mammary gland, and in turn may aid in the early diagnosis. / FAPESP: 14/19321-4 / FAPESP: 14/25309-7 / FAPESP: 16/10526-8

A presença de resíduos de medicamentos antibacterianos em alimentos é um importante problema de saúde pública. Estas substâncias podem estar presentes nos alimentos em níveis inaceitáveis como resultados de práticas produtivas inadequadas. Devido a estas preocupações, são estabelecidos limites máximos de resíduos para estas substâncias (LMRs). No caso das sulfonamidas, este valor de LMR refere-se à soma do princípio ativo e de todos seus metabólitos. Neste trabalho, identificam-se e caracterizam-se metabólitos de sulfaquinoxalina (SQX) em diversas espécies animais. Dentro do processo investigativo, foram realizados estudos comparativos de métodos de extração, processos de validação e determinação de efeito de matriz. Foi elaborado e proposto um modelo para a priorização de fármacos baseado em análise de risco e discutiu-se o panorama atual da presença de resíduos de sulfonamidas em amostras ambientais. A investigação da formação de metabólitos de SQX in vitro e in vivo levaram à identificação de três compostos, dois deles ainda não descritos na literatura: N4-acetil-SQX, SQX-OH e N4-acetil-SQX-OH. O perfil de formação destes compostos em diversas espécies animais foi analisado e discutido. / The presence of antibacterial drugs residues in food is an important public health issue. These substances can be present in food at unacceptable levels due to inappropriate veterinary practices. Because of that, maximum residue levels (MRL) are established for these compounds. In the sulfonamide drugs case, this value corresponds to the sum of parent drug and their metabolites. In the present work, sulfaquinoxaline (SQX) metabolites were identified and characterized in several animal species. Inside that investigation process, several studies were developed about extraction methods, validation processes and matrix effects determination. A model for drugs residues prioritization based on risk analysis was proposed. Also, the state-of-art of sulfonamides residues analysis in environmental samples was discussed. The in vivo and in vitro investigation of SQX metabolites formation lead us to the identification of 3 compounds, 2 of them previously unreported: N4-acetyl-SQX, SQX-OH and N4-acetyl-SQX-OH. The formation profile of these compounds in several animal species was analyzed and discussed.